![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ||
Founding Date | Founding Date 1781 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | |
Employees | Employees 47,4554% decrease | Employees 82517% decrease |
Valuation ($) | Valuation ($) 43.7 b | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) €535.2m (FY, 2024) |
Cost of goods | Cost of goods ¥818.8b (FY, 2025) | Cost of goods €9.7m (FY, 2024) |
Gross profit | Gross profit ¥3.8t (FY, 2025) | Gross profit €534.4m (FY, 2024) |
Net income | Net income ¥108.1b (FY, 2025) | Net income €162.2m (FY, 2024) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products 3 (May, 2020) |
Funding | ||
Total funding raised | Total funding raised $ 57.8m | Total funding raised $ 1.1b |

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company